Multivariate analysis of factors predictive of brain metastases in localised non-small cell lung carcinoma

Lung Cancer

Volumn 45, Issue 3, 2004, Pages 317-323

  Bajard, A ^a   Westeel, V ^a   Dubiez, A ^a   Jacoulet, P ^a   Pernet, D ^a   Dalphin, J C ^a   Depierre, A ^a  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

Brain metastasis; Non small cell lung cancer; Prognostic factor

Indexed keywords

CISPLATIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; SEX DIFFERENCE; SURVIVAL TIME; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; WEIGHT REDUCTION;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; COHORT STUDIES; CRANIAL IRRADIATION; DISEASE PROGRESSION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PATIENT SELECTION; PROGNOSIS; RISK FACTORS;

EID: 3843102736     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2004.01.025     Document Type: Article

References (25)

1. Gilbert S., Reid K.R., Lam M.Y., Petsikas D. Who should follow up lung cancer patients after operation? Ann Thorac Surg. 69(6):2000;1696-1700
2. Virgo K.S., McKirgan L.W., Caputo M.C., Mahurin D.M., Chao L.C., Caputo N.A., et al. Post-treatment management options for patients with lung cancer. Ann Surg. 222(6):1995;700-710
3. Martini N., Burt M.E., Bains M.S., McCormack P.M., Rusch V.W., Ginsberg R.J. Survival after resection of stage II non-small cell lung cancer. Ann Thorac Surg. 54(3):1992;460-465
4. Walsh G.L., O'Connor M., Willis K.M., Milas M., Wong R.S., Nesbitt J.C., et al. Is follow-up of lung cancer patients after resection medically indicated and cost-effective? Ann Thorac Surg. 60(6):1995;1563-1570
5. Yano T., Yokoyama H., Inoue T., Asoh H., Tayama K., Takai E., et al. The first site of recurrence after complete resection in non-small-cell carcinoma of the lung. Comparison between pN0 disease and pN2 disease. J Thorac Cardiovasc Surg. 108(4):1994;680-683
6. Yokoi K., Miyazawa N., Arai T. Brain metastasis in resected lung cancer: value of intensive follow-up with computed tomography. Ann Thorac Surg. 61(2):1996;546-550
7. Younes R.N., Gross J.L., Deheinzelin D. Follow-up in lung cancer: how often and for what purpose? Chest. 115(6):1999;1494-1499
8. Auperin A., Arriagada R., Pignon J.P., Le Pechoux C., Gregor A., Stephens R.J., et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission: Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med. 341(7):1999;476-484
9. Cox J.D., Stanley K., Petrovich Z., Paig C., Yesner R. Cranial irradiation in cancer of the lung of all cell types. J Am Med Assoc. 245(5):1981;469-472
10. Jacobs R.H., Awan A., Bitran J.D., Hoffman P.C., Little A.G., Ferguson M.K., et al. Prophylactic cranial irradiation in adenocarcinoma of the lung: a possible role. Cancer. 59(12):1987;2016-2019
11. Russell A.H., Pajak T.E., Selim H.M., Paradelo J.C., Murray K., Bansal P., et al. Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: results of a prospective randomized trial conducted by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys. 21(3):1991;637-643
12. Stuschke M., Eberhardt W., Pottgen C., Stamatis G., Wilke H., Stuben G., et al. Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuropsychologic effects. J Clin Oncol. 17(9):1999;2700-2709
13. Umsawasdi T., Valdivieso M., Chen T.T., Barkley H.T. Jr., Booser D.J., Chiuten D.F., et al. Role of elective brain irradiation during combined chemoradiotherapy for limited disease non-small cell lung cancer. J Neurooncol. 2(3):1984;253-259
14. Mountain C.F. Revisions in the international system for staging lung cancer. Chest. 111(6):1997;1710-1717
15. WHO handbook for reporting results of cancer treatment. Geneva: WHO; 1979.
16. Kaplan E.L., Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481
17. Ceresoli G.L., Reni M., Chiesa G., Carretta A., Schipani S., Passoni P., et al. Brain metastases in locally advanced non-small cell lung carcinoma after multimodality treatment: risk factors analysis. Cancer. 95(3):2002;605-612
18. Andre F., Grunenwald D., Pujol J.L., Girard P., Dujon A., Brouchet L., et al. Patterns of relapse of N2 non-small-cell lung carcinoma patients treated with preoperative chemotherapy: should prophylactic cranial irradiation be reconsidered? Cancer. 91(12):2001;2394-2400
19. Robnett T.J., Machtay M., Stevenson J.P., Algazy K.M., Hahn S.M. Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small-cell lung carcinoma. J Clin Oncol. 19(5):2001;1344-1349
20. Schouten L.J., Rutten J., Huveneers H.A., Twijnstra A. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer. 94(10):2002;2698-2705
21. Tang S.G., Lin F.J., Leung W.M. Impact of prophylactic cranial irradiation in adenocarcinoma of the lung. J Formos Med Assoc. 92(5):1993;413-419
22. Fidler I.J., Yano S., Zhang R.D., Fujimaki T., Bucana C.D. The seed and soil hypothesis: vascularisation and brain metastases. Lancet Oncol. 3(1):2002;53-57
23. Komaki R., Meyers C.A., Shin D.M., Garden A.S., Byrne K., Nickens J.A., et al. Evaluation of cognitive function in patients with limited small-cell lung cancer prior to shortly following prophylactic cranial irradiation. Int J Radiat Oncol Biol Phys. 33(1):1995;179-182
24. Eberhardt W., Wilke H., Stamatis G., Stuschke M., Harstrick A., Menker H., et al. Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial. J Clin Oncol. 16(2):1998;622-634
25. Westeel V., Choma D., Clement F., Woronoff-Lemsi M.C., Pugin J.F., Dubiez A., et al. Relevance of an intensive postoperative follow-up after surgery for non-small cell lung cancer. Ann Thorac Surg. 70(4):2000;1185-1190